NanoVibronix Inc NAOV has commenced sales in Europe by signing a distribution agreement with Medina Healthcare Ltd for UroShield and PainShield devices.
- UroShield is an ultrasound-based product designed to prevent bacterial colonization and biofilm on indwelling urinary catheters and increase antibiotic efficacy, ultimately reducing the incidence of catheter-associated urinary tract infections (CAUTI).
- Related: NanoVibronix Shares Gain As PainShield Shows Effectiveness In Treating Soft Tissue Pain.
- UroShield is also intended to decrease pain and discomfort associated with urinary catheter use.
- PainShield is an ultrasound device consisting of a reusable driver unit and a disposable patch.
- PainShield delivers a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area while keeping the level of ultrasound energy at a safe and consistent level.
- Price Action: NAOV shares are up 2.84% at $1.07 during the market session on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in